Nonspecific (BCG) immunotherapy of human solid tumors
β Scribed by John R. Langley; William Hotchkiss; Francis E. Rosato
- Publisher
- Elsevier Science
- Year
- 1977
- Tongue
- English
- Weight
- 181 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Fifty-one patients with confirmed bladder cancer have enrolled in a prospective evaluation of BCG immunotherapy. Following resection of existing tumors, patients were stratified according to tumor grade and number of previous recurrences and randomly assigned to control or BCG treatment groups. Immu
Bacillus Calmette-Guirin (BCG) was administered in various doses by four different routes to C3H/HeJ mice bearing wellestablished syngeneic MC-42 fibrosarcomas. Injections of BCG into established primary tumors decreased survival of tumor-bearing mice as compared to saline-injected controls. Of the
## Abstract The mononuclear cell content and mononuclear cell function of human solid tumors were determined. Twentyβeight primary, and 17 metastatic solid tumors, including 6 lymph node metastases, were obtained from 45 patients. Cells were released from the tumors by mincing, scraping, and sievin